Form 13-F position report

ENFUSION INC

Reported by MORGAN STANLEY

ENFN CUSIP 292812104 Manager CIK 0000895421

Reported 39,158 shares, up 35,692 (1029.8%) from the prior quarter.

Reported value 830.2%; share count 1029.8% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 39,158 Quarter-end amount reported
Reported value $400,000 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 55000
2022-03-31 43000
2022-06-30 400000
2022-09-30 346000
2022-12-31 145407
2023-03-31 1156199
2023-06-30 1412216
2023-09-30 1557157
2023-12-31 1812367
2024-03-31 1144171
2024-06-30 2473178
2024-09-30 4093206
2024-12-31 5366290
2025-03-31 3147712
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for ENFUSION INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -282,306 (-100.0%) 0 $0 2025-08-15
Q1 2025 Reduced 282,306 -238,693 (-45.8%) < 0.01% $3,147,712 2025-05-15
Q4 2024 Added 520,999 +89,681 (20.8%) < 0.01% $5,366,290 2025-02-14
Q3 2024 Added 431,318 +141,039 (48.6%) < 0.01% $4,093,206 2024-11-14
Q2 2024 Added 290,279 +166,585 (134.7%) < 0.01% $2,473,178 2024-08-14
Q1 2024 Reduced 123,694 -63,148 (-33.8%) < 0.01% $1,144,171 2024-05-15
Q4 2023 Added 186,842 +13,246 (7.6%) < 0.01% $1,812,367 2024-02-13
Q3 2023 Added 173,596 +47,730 (37.9%) < 0.01% $1,557,157 2023-11-15
Q2 2023 Added 125,866 +15,752 (14.3%) < 0.01% $1,412,216 2023-08-14
Q1 2023 Added 110,114 +95,077 (632.3%) < 0.01% $1,156,199 2023-05-15
Q4 2022 Reduced 15,037 -13,076 (-46.5%) < 0.01% $145,407 2023-02-14
Q3 2022 Reduced 28,113 -11,045 (-28.2%) < 0.01% $346,000 2022-11-14
Q2 2022 Added 39,158 +35,692 (1029.8%) < 0.01% $400,000 2022-08-15
Q1 2022 Added 3,466 +870 (33.5%) < 0.01% $43,000 2022-05-13
Q4 2021 New 2,596 +2,596 (0.0%) < 0.01% $55,000 2022-02-14

Who else reported the position

77 managers reported ENFUSION INC for Q2 2022.

Managers reporting ENFUSION INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FTV Management Company L P Unchanged 31,297,606 0 81.08% $319,548,557 3 qtrs
ICONIQ Capital LLC Unchanged 14,039,594 0 1.7% $143,344,000 3 qtrs
Dragoneer Investment Group LLC Unchanged 6,490,000 0 1.7% $66,263,000 3 qtrs
HHLR ADVISORS LTD Unchanged 4,975,183 0 1.09% $50,797,000 3 qtrs
ALLIANCEBERNSTEIN L P Added 2,493,360 +17,271 0.01% $25,457,000 3 qtrs
BROWN CAPITAL MANAGEMENT LLC New 2,391,611 +2,391,611 0.33% $24,418,000 1 qtr
Ararat Capital Management LP Added 2,212,120 +302,295 8.12% $22,586,000 3 qtrs
TimesSquare Capital Management LLC Added 1,643,505 +12,200 0.23% $16,780,000 3 qtrs
BlackRock Inc Added 1,584,633 +241,930 < 0.01% $16,181,000 3 qtrs
VANGUARD GROUP INC Reduced 1,408,356 -323,563 < 0.01% $14,379,000 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
CL A

Voting authority reported

Sole
36,187
Shared
152
None
2,819

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.